Xenon Pharmaceuticals Inc. logo

Xenon Pharmaceuticals Inc.

NASDAQ:XENE

Overview | Financials
Company Name Xenon Pharmaceuticals Inc.
Symbol XENE
Currency USD
Price 30.87
Market Cap 2,368,766,232
Dividend Yield 0%
52-week-range 26.74 - 46
Industry Biotechnology
Sector Healthcare
CEO Mr. Ian C. Mortimer C.M.A., CPA, CMA, CPA, M.B.A., MBA
Website https://www.xenon-pharma.com

An error occurred while fetching data.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium

Related Stocks

Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc.

TVTX

15.53 USD

Krystal Biotech, Inc. logo

Krystal Biotech, Inc.

KRYS

152.08 USD

ImmunityBio, Inc. logo

ImmunityBio, Inc.

IBRX

2.54 USD

Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc.

ESTA

41.23 USD

Addus HomeCare Corporation logo

Addus HomeCare Corporation

ADUS

107.89 USD

Ligand Pharmaceuticals Incorporated logo

Ligand Pharmaceuticals Incorporated

LGND

131.58 USD

Dynavax Technologies Corporation logo

Dynavax Technologies Corporation

DVAX

11.19 USD

Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc.

SUPN

33.45 USD

ModivCare Inc. logo

ModivCare Inc.

MODV

3.02 USD

Financials

Numbers are in millions USD

Numbers are in millions USD